DUBLIN--(BUSINESS WIRE)--May 12, 2026-- Alkermes plc (Nasdaq: ALKS) today announced positive topline results from the REVITALYZ℠ double-blind, placebo-controlled,...
The Wake Up Narcolepsy (WUN) 2026 National Summit took place on April 25th, at the...
BOSTON, April 29, 2026 – The Institute for Clinical and Economic Review (ICER) today posted its revised Evidence...
DUBLIN--(BUSINESS WIRE)--Apr. 16, 2026-- Alkermes plc (Nasdaq: ALKS) today announced plans to present new data from the...
Wake Up Narcolepsy (WUN)'s 2026 Family Weekend took place March 27th - 29th at the...
DUBLIN--(BUSINESS WIRE)--Apr. 1, 2026-- Alkermes plc (Nasdaq: ALKS) today announced the initiation of the Brilliance Studies, a...
INDIANAPOLIS and BOSTON and LONDON, March 31, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company...
Join us on April 9th at 2pm ET for our next Brown Bag Webinar, “Navigating...
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Feb. 17, 2026-- Harmony Biosciences (Nasdaq: HRMY) today announced that the U.S. Food and Drug...
DUBLIN--(BUSINESS WIRE)--Feb. 12, 2026-- Alkermes plc (Nasdaq: ALKS) (“Alkermes”) and Avadel Pharmaceuticals plc (Nasdaq: AVDL) (“Avadel”) today announced Alkermes’...